LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Clinical trials for LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for slowing advanced neuroendocrine tumors in Final-Stage trial
Disease control OngoingThis study is testing whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo in people whose cancer has continued to worsen despite prior treatments. About 298 participants with specific advanced neuroendocrine tumors will be ran…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for Tough-to-Treat digestive tumors
Disease control OngoingThis study is testing whether the drug abemaciclib can help control advanced digestive system neuroendocrine tumors that have spread and stopped responding to standard treatments. The drug works by blocking enzymes that tumor cells need to grow. About 20 patients with these speci…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC